ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 1 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | – | 53 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 53 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 53 | -99.1% | 0.00% | – |
| Q1 2018 | $8,000 | -27.3% | 6,202 | +30.7% | 0.00% | – |
| Q4 2017 | $11,000 | +450.0% | 4,746 | +601.0% | 0.00% | – |
| Q3 2017 | $2,000 | – | 677 | +840.3% | 0.00% | – |
| Q2 2017 | $0 | – | 72 | -61.7% | 0.00% | – |
| Q1 2017 | $0 | – | 188 | +254.7% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 53 | -84.2% | 0.00% | – |
| Q3 2016 | $1,000 | – | 335 | +532.1% | 0.00% | – |
| Q2 2016 | $0 | – | 53 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 53 | -95.2% | 0.00% | – |
| Q4 2015 | $3,000 | +50.0% | 1,111 | +15.0% | 0.00% | – |
| Q3 2015 | $2,000 | -60.0% | 966 | -25.6% | 0.00% | – |
| Q2 2015 | $5,000 | -16.7% | 1,298 | +30.1% | 0.00% | – |
| Q1 2015 | $6,000 | -33.3% | 998 | -67.9% | 0.00% | – |
| Q4 2014 | $9,000 | – | 3,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 5,292,156 | $11,907,000 | 1.66% |
| Northeast Financial Consultants Inc | 732,265 | $1,647,000 | 0.55% |
| AJ WEALTH STRATEGIES, LLC | 29,624 | $67,000 | 0.02% |
| Family Management Corp | 10,424 | $23,000 | 0.02% |
| Virtu Financial LLC | 71,588 | $161,000 | 0.01% |
| Poehling Capital Management, INC. | 2,802 | $6,000 | 0.01% |
| Founders Capital Management | 2,000 | $5,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $333,000 | 0.00% |
| WEDBUSH SECURITIES INC | 11,000 | $25,000 | 0.00% |
| THRIVENT FINANCIAL FOR LUTHERANS | 298,303 | $671,000 | 0.00% |